Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The harmful effects of high-intensity (HI) and long duration (LD) exercise have been reported in arrhythmogenic right ventricular cardiomyopathy, including in asymptomatic genetic variant carriers. However, the impact of exercise remains unclear in desmoplakin (DSP) gene variant carriers at risk of arrhythmogenic left ventricular cardiomyopathy (ALVC).

Objectives: The goal of this study was to assess the relationship between HI and LD exercise and the risk of developing an ALVC phenotype and its severity in DSP variant carriers.

Methods: In a monocentric retrospective study, patients with DSP pathogenic or likely pathogenic variant were interviewed about their exercise practice before genetic or disease diagnosis. HI and LD exercise were defined as having practiced at least one sport with an intensity ≥6 METs and ≥2.5 hours/week, respectively. We studied the association of HI and LD exercise practice with the risk of ALVC phenotype occurrence at diagnosis.

Results: A total of 85 patients were included (mean age 39 ± 19 years; 49% female). Sixty-nine percent had practiced HI exercise and 66% LD exercise. The rate of patients with an ALVC phenotype at time of diagnosis did not differ between patients having practiced HI and LD exercise and those who had not (71% vs 65% [P = 0.60] and 70% vs 69% [P = 0.95]). The distribution of prior calculated exercise dose was not different between patients with vs those without ALVC phenotype at diagnosis (P = 0.57).

Conclusions: Prior exercise intensity, duration, and cumulated lifetime dose were not associated with an increased risk of developing an ALVC phenotype at the time of diagnosis in DSP variant carriers.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacep.2025.05.007DOI Listing

Publication Analysis

Top Keywords

alvc phenotype
20
exercise
12
exercise practice
12
ventricular cardiomyopathy
12
variant carriers
12
prior exercise
8
arrhythmogenic left
8
left ventricular
8
risk developing
8
developing alvc
8

Similar Publications

Background: The harmful effects of high-intensity (HI) and long duration (LD) exercise have been reported in arrhythmogenic right ventricular cardiomyopathy, including in asymptomatic genetic variant carriers. However, the impact of exercise remains unclear in desmoplakin (DSP) gene variant carriers at risk of arrhythmogenic left ventricular cardiomyopathy (ALVC).

Objectives: The goal of this study was to assess the relationship between HI and LD exercise and the risk of developing an ALVC phenotype and its severity in DSP variant carriers.

View Article and Find Full Text PDF

Arrhythmogenic cardiomyopathy (ACM) is a genetically inherited cardiomyopathy characterised by the fibro-fatty replacement of the myocardium. Patients can present with symptoms of arrhythmia or heart failure; it is a common cause of sudden cardiac arrest and death in young adults. Originally considered as right ventricular arrhythmogenic cardiomyopathy or dysplasia, this terminology has been updated to include left-dominant and biventricular phenotypes.

View Article and Find Full Text PDF

Background: Arrhythmogenic cardiomyopathy (ACM) characterized by progressive myocardial loss and replacement with fibro-fatty tissue is a major cause of sudden cardiac death (SCD). In particular, ACM with predominantly left ventricular involvement, known as arrhythmogenic left ventricular cardiomyopathy (ALVC), has a poor prognosis.

Methods: The proband underwent whole-exome sequencing (WES) to determine the etiology of ALVC.

View Article and Find Full Text PDF

Background: Arrhythmogenic left ventricular cardiomyopathy (ALVC) is characterized by fibrofatty myocardial replacement demonstrated on cardiac magnetic resonance by late gadolinium enhancement (LGE) mainly involving the subepicardium. The aims of this study were to describe the layer-specific strain (LSS) echocardiography phenotype of ALVC and to compare it with LGE features.

Methods: All consecutive ALVC pathogenic genetic variant carriers and noncarrier relatives were separated into four prespecified groups (overt ALVC [group 1], isolated LGE [group 2], pathogenic genetic variant carrier without ALVC phenotype [group 3], and no genetic variant carrier [group 4]) and studied accordingly using cardiac magnetic resonance and LSS echocardiography.

View Article and Find Full Text PDF
Article Synopsis
  • Left ventricular arrhythmogenic cardiomyopathy (ALVC) is a rare heart condition that has been reclassified as a type of non-dilated cardiomyopathy, and the review highlights its background, diagnosis, and risks of sudden cardiac death.
  • There is limited data on ALVC, but it is recognized as a specific disease affecting the left ventricle, necessitating updated management strategies and understanding of associated risks.
  • Diagnosis involves a comprehensive approach using cardiac magnetic resonance imaging and genetic testing, which are crucial for assessing the risk of sudden cardiac death and improving patient management, with more research needed to enhance knowledge about the condition.
View Article and Find Full Text PDF